Altered Transcriptional Regulation of Glycolysis in Circulating CD8+ T Cells of Rheumatoid Arthritis Patients

Abstract

Peripheral T lymphocytes of rheumatoid arthritis (RA) patients show pathological changes in their metabolic pathways, especially glycolysis. These changes may drive the increased proliferation and tissue invasiveness of RA T cells. In order to study the transcriptional regulation underlying these alterations, we analysed publicly available RNA sequencing data from circulating T lymphocyte subsets of healthy individuals, untreated RA patients, and patients undergoing treatment for RA. Differential co-expression networks were created using sample-wise edge weights from an analysis called “linear interpolation to obtain network estimates for single sample” (lionessR), and annotated using the Gene Transcription Regulation Database (GTRD). Genes with high centrality scores were identified. CD8+ effector memory cells (Tem) and CD8+CD45RA+ effector memory cells (Temra) showed large changes in the transcriptional regulation of glycolysis in untreated RA. PFKFB3 and GAPDH were differentially regulated and had high centrality scores in CD8+ Tem cells. PFKFB3 downregulation may be due to HIF1A post transcriptional inhibition. Tocilizumab treatment partially reversed the RA-associated differential expression of several metabolic and regulatory genes. MYC was upregulated and had high centrality scores in RA CD8+ Temra cells; however, its glycolysis targets were unaltered. The upregulation of the PI3K-AKT and mTOR pathways may explain MYC upregulation.

Pathogenesis of rheumatoid arthritis: one year in review 2023

“…In CD4 + T cells from RA patients the tricarboxylic acid TCA cycle and fatty acid oxidation are deeply defective, leading to the accumulation of lipid droplets and the formation of large membrane structures, promoting tissue invasion. In parallel, in untreated RA CD8 + T cells, but not in healthy control, an elevated rate of aerobic glycolysis, lactate production as well as high levels of ROS were detected (49).…”

Unveiling the link between lactate metabolism and rheumatoid arthritis through integration of bioinformatics and machine learning

“…There is a positive correlation between FOS and nuclear factor interleukin 3 (NFIL3) in the peripheral blood of RA patients, as well as an abnormal inflammatory cytokine and inflammatory response linked to high NFIL3 expression 56 . RA-induced activation of the PI3K-AKT and mTOR signaling cascades could potentially enhance MYC expression in TEMRA CD8+ T cells, consequently modulating the glycolysis transcriptional pathway in RA 57 . The mRNA-drug interactions network lists 16 drugs that might have potential therapeutic effects in RA.…”

Augmenting regulatory T cells: new therapeutic strategy for rheumatoid arthritis

“…Data from RA patients treated with tocilizumab show an increase in Treg numbers after treatment, consistent with a good clinical response ( 57 , 168 , 169 ). IL-6 is a major driver of increased inflammation in RA patients, and tocilizumab has been shown to treat RA patients and alleviate their disease ( 170 – 172 ).…”